TRI-JORDYNA 28
Identification of Tri-Jordyna 28
| No description |
Google image searchProduct monograph
Active ingredients
ethinyl estradiol, 0.035 MG
norgestimate, 0.18 MG
norgestimate, 0.215 MG
ethinyl estradiol, 0.035 MG
norgestimate, 0.25 MG
ethinyl estradiol, 0.035 MG
DIN: 02486318
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: GLENMARK PHARMACEUTICALS CANADA INC.
Date: 18-MAR-2020
ATC:
- G03 — SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM (ATC, ATC/DDD, )
- G03A — HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE (ATC, ATC/DDD)
- G03AB — Progestogens and estrogens, sequential preparations (ATC, ATC/DDD)
- G03AB09 — NORGESTIMATE AND ETHINYLESTRADIOL (ATC/DDD)
Reference brand drug: Tri-cira
Pharmaceutical standard: USP
External Links for Tri-Jordyna 28
Search on Google
- Tri-Jordyna 28 side effects
- Tri-Jordyna 28 dosage
- ethinyl estradiol side effects
- ethinyl estradiol dosage
- norgestimate side effects
- norgestimate dosage
- norgestimate side effects
- norgestimate dosage
- ethinyl estradiol side effects
- ethinyl estradiol dosage
- norgestimate side effects
- norgestimate dosage
- ethinyl estradiol side effects
- ethinyl estradiol dosage
